Figure 2From: Phosphorylation of mTOR and S6RP predicts the efficacy of everolimus in patients with metastatic renal cell carcinoma Kaplan–Meier estimates of progression-free survival (PFS) according to expression of phospho-mTOR ( A ) and phospho-S6RP ( B ). Back to article page